Micropropagation

EQS-News: This Company Looks To Change The AgTech Industry With The Help Of Some Strategic M&A

Retrieved on: 
Wednesday, November 30, 2022

The company has recently announced and has pending a series of acquisitions , including data and consulting company Delphy Group, biotech company Deroose Plants NV and IP from Manna Nutritional Group (MNG).

Key Points: 
  • The company has recently announced and has pending a series of acquisitions , including data and consulting company Delphy Group, biotech company Deroose Plants NV and IP from Manna Nutritional Group (MNG).
  • AgriFORCEs clear mission to the agricultural industry is supported by four pillars:
    1) Facility and lighting design.
  • Another company AgriFORCE has publicly announced a Binding Letter of Intent is leading tissue-culture and young plants company Deroose Plants.
  • The company is excited for 2023 as it proceeds to launch its (UN)THINK food brand of high-protein, high-fiber, low-carb grains.

Global Micropropagation Market Report (2022 to 2027) - Demand for Tissue-Cultured Industrial & Food Crops Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, August 26, 2022

The micropropagation market allows vendors to produce and export crops such as ornamental flowers, bananas, tomatoes, corn and others.

Key Points: 
  • The micropropagation market allows vendors to produce and export crops such as ornamental flowers, bananas, tomatoes, corn and others.
  • The production of high-quality planting materials is rising with the increased tissue cultured industrial crops, and food crops are expected to anticipate the growth of micropropagation in the forecast period.
  • As a result, farmers' incomes are diversified, increasing sustainability and the need to replicate industrial crops and food crops through micropropagation technology.
  • The growing interest in homegrown production and plant tissue culture market is expected to anticipate the growth of the micropropagation market.

DNA Genetics Announces Partnership With Cannabis Tissue Culture Company Meristematic

Retrieved on: 
Monday, January 11, 2021

LOS ANGELES, Jan. 11, 2021 (GLOBE NEWSWIRE) -- OG DNA Genetics (DNA or the Company), a globally recognized leading cannabis brand, today announced a partnership agreement (the Agreement) with Meristematic, Inc. (Meristematic), a leading cannabis micropropagation and tissue culture provider in California.

Key Points: 
  • LOS ANGELES, Jan. 11, 2021 (GLOBE NEWSWIRE) -- OG DNA Genetics (DNA or the Company), a globally recognized leading cannabis brand, today announced a partnership agreement (the Agreement) with Meristematic, Inc. (Meristematic), a leading cannabis micropropagation and tissue culture provider in California.
  • Meristematics Clean Cultivar Program uses proprietary tissue culture processes to rejuvenate mother plants while simultaneously filtering out diseases and pests.
  • This program allows cultivators to enjoy some of the benefits of tissue culture, without building a lab or hiring expensive staff to manage a tissue culture program.
  • The benefits of tissue culture and genetic marker identification for a cannabis genetic company cannot be overstated, said Don Morris, Co-Founder and Chief Cannabis Officer of DNA Genetics.

Way2Grow (W2G) Biopharma Company Receives Health Canada Standard Cultivation License, Processing License and Medical Sales License

Retrieved on: 
Tuesday, December 8, 2020

The terms of the licenses include approval of a single-story production facility designed to support micropropagation tissue culture, organic cultivation, processing and medical sales requirements.

Key Points: 
  • The terms of the licenses include approval of a single-story production facility designed to support micropropagation tissue culture, organic cultivation, processing and medical sales requirements.
  • Phase II plans include the expansion of the research laboratory, expansion of controlled cultivation rooms and the addition of a medical dispensary.
  • The W2G cultivation relies on a small, closed room approach to grow consistent organic medical cannabis.
  • Each cultivation room then operates specific to the cultivars growth plan and cultivar optimal conditions to create consistent medical quality.

Conception Receives Prestigious Award From Arcview Investor Forum

Retrieved on: 
Friday, January 10, 2020

PORTLAND, Ore., Jan. 10, 2020 /PRNewswire/ -- Conception , a leading cannabis micropropagation company, has received the prestigious Ready to Invest award at The Arcview Group 's inaugural Investor Intelligence Conference.

Key Points: 
  • PORTLAND, Ore., Jan. 10, 2020 /PRNewswire/ -- Conception , a leading cannabis micropropagation company, has received the prestigious Ready to Invest award at The Arcview Group 's inaugural Investor Intelligence Conference.
  • "We're thrilled that Arcview recognized the disruptive nature of our business and honored that this forward-thinking group chose to invest in Conception," said Kevin Brooks, CEO of Conception Nurseries.
  • Judges highlighted Conception Nurseries as an innovative company helping cannabis cultivators access nursery programs they historically didn't have access to.
  • With tissue culture micropropagation, Conception produces plantlets that are free of pathogens and have exceptional vigor, aiming to reduce producers' in-house costs.

Node Labs Inc Announces Patent-pending production process and Facility Expansion to Dramatically Increase Production

Retrieved on: 
Thursday, December 5, 2019

SONOMA COUNTY, Calif., Dec. 5, 2019 /PRNewswire/ --Node Labs Inc. a leader in cannabis tissue culture, today announced its patent-pending micropropagation technology.

Key Points: 
  • SONOMA COUNTY, Calif., Dec. 5, 2019 /PRNewswire/ --Node Labs Inc. a leader in cannabis tissue culture, today announced its patent-pending micropropagation technology.
  • Developed over two years of research, this technology allows Node to produce pathogen-free plantlets at scale without compromising the integrity of the plant.
  • Node also announced the launch of its second facility in California, more than quadrupling the production capacity.
  • Node Labs specializes in cleaning, restoration, and long-term storage of strains for cultivators and breeders.

Segra enters into Strategic Plant Genotyping and Tissue Culture Agreement with Sugarbud

Retrieved on: 
Thursday, December 5, 2019

VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. ("Segra") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) ("Sugarbud") through its wholly owned subsidiary Segra Biogenesis Corp.

Key Points: 
  • VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. ("Segra") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) ("Sugarbud") through its wholly owned subsidiary Segra Biogenesis Corp.
  • Under the terms of the agreement, which includes royalties tied to production success, Segra will provide Sugarbud with exclusive and proprietary cannabis cultivars as well as tissue culture technology and services for the preservation, regeneration, and production of key cultivars already held by Sugarbud.
  • Plant tissue culture, also known as plant micropropagation, is an advanced scientific technique utilized in many commercial agricultural applications to mass-produce plants with desirable traits.
  • To support this vision, Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance.

Sugarbud enters into Strategic Plant Genotyping and Tissue Culture Agreement with Segra

Retrieved on: 
Thursday, December 5, 2019

CALGARY, Alberta, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) ("Sugarbud") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Segra Biogenesis Corp., a wholly owned subsidiary of Segra International Corp. ("Segra").

Key Points: 
  • CALGARY, Alberta, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) ("Sugarbud") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Segra Biogenesis Corp., a wholly owned subsidiary of Segra International Corp. ("Segra").
  • Under the terms of the agreement, which include royalties tied to production success, Segra will provide Sugarbud with exclusive and proprietary cannabis cultivars as well as tissue culture technology and services for the preservation, regeneration, and production of key cultivars already held by Sugarbud.
  • Plant tissue culture, also known as plant micropropagation, is an advanced scientific technique utilized in many commercial agricultural applications to mass-produce plants with desirable traits.
  • To support this vision, Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance.

Conception Nurseries, a Leading Cannabis Micropropagation Company, Comes out of Quiet Production and Launches Publicly Today

Retrieved on: 
Wednesday, January 16, 2019

Conception Nurseries, a cannabis micropropagation company that has been quietly developing cannabis tissue culture clones for nearly two years, is now launching publicly.

Key Points: 
  • Conception Nurseries, a cannabis micropropagation company that has been quietly developing cannabis tissue culture clones for nearly two years, is now launching publicly.
  • Conception is bringing tissue culture technology, a crucial component of industrial scale agriculture, to the cannabis industry.
  • With tissue culture micropropagation, Conception produces plantlets that are free of pathogens and have exceptional vigor, at a cost-per-plant below producers' in-house costs.
  • Kevin most recently served as the CEO of Connected Cannabis, the largest vertically integrated cannabis company in California.

Wonderland Nursery Unveils New Tissue Culture Clones at Emerald Cup

Retrieved on: 
Tuesday, December 11, 2018

HUMBOLDT, Calif., Dec. 11, 2018 /PRNewswire/ -- Wonderland Nursery , Humboldt County's premier provider of ultra-high quality tissue culture clones, announced that it will be unveiling its new technology and plants at Emerald Cup.

Key Points: 
  • HUMBOLDT, Calif., Dec. 11, 2018 /PRNewswire/ -- Wonderland Nursery , Humboldt County's premier provider of ultra-high quality tissue culture clones, announced that it will be unveiling its new technology and plants at Emerald Cup.
  • Wonderland Nursery's process uses advanced tissue culture micropropagation, which cleans the source material of any contamination, and creates clones with perfect genetic matches - without any degradation of desirable traits.
  • Kevin Jodrey, a partner in Wonderland Nursery and one of the world's leading cultivators, will be speaking at Emerald Cup about the advantages of using tissue culture micropropagation.
  • For information on Wonderland Nursery, call: (707) 923-2175 or visit: www.wonderlandnursery.com
    For information on Emerald Cup visit: theemeraldcup.com/